About FAScinate Therapeutics
FAScinate is a clinical-stage company that develops disease-modifying drugs for neurodegenerative diseases such as Parkinson's disease (PD) and multiple system atrophy (MSA).
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Biotechnology, Therapeutics, VR/AR
Investor Type
Private Equity Firm, Venture Capital
Investment Focus
Focus Areas